SkinCure Oncology Reports Higher Skin Cancer Incidence
Burr Ridge, Illinois, U.S., September 17, 2026 SkinCure Oncology has reported a new analysis suggesting that the annual number...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine solid tumors targeted therapy
Burr Ridge, Illinois, U.S., September 17, 2026 SkinCure Oncology has reported a new analysis suggesting that the annual number...
BAGSVAERD, Denmark — September 14, 2026 Novo Nordisk A/S announced the launch of a new corporate brand centred on...
MONMOUTH JUNCTION, N.J. — September 14, 2026 Tris Pharma, Inc. announced the availability of a new 30-count bottle size...
PARIS, France — September 14, 2026 Sanofi and Cheplapharm announced plans to create a new strategic partnership under which...
Abbott Park, Illinois and Bethesda, Maryland, August 17, 2026 Abbott and the National Association of Community Health Centers (NACHC)...
ISELIN, N.J., August 14, 2026 Outlook Therapeutics, Inc. is advancing preparations for the U.S. commercial launch of LYTENAVAâ„¢ (bevacizumab-vikg)...
